Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis

Table 1

Demographic, clinical and echocardiographic data of decompensated cirrhotic patients enrolled in the study.

Parameters	Patients ()
Age in years	(26-65)
Gender	Male 70 (76%); Female 22 (24%)
Etiology	Cryptogenic 45 (49%); Alcohol 30 (33%); HBV 13 (14%); HCV 2 (2%); Autoimmune 2 (2%)
Albumin (g/dl)	(1.6-3.8)
Bilirubin (mg/dl)	(0.9-13.5)
INR (s)	(1-3.7)
Creatinine (mg/dl)	(0.5-5.5)
MELD	(7-36)
CTP	A 7 (7.6%); B 34 (36.9%); C 51 (55.5%)
Echocardiographic findings	LVEF (26-68); Mitral ratio (0.68-3.04); (6-18); Deceleration time (126-274); LAVI (19-49)

Abbreviations: LVDD: left ventricular diastolic dysfunction; HBV: hepatitis B virus; HCV: hepatitis C virus; INR: international normalized ratio; MELD: model for end-stage liver disease; LVEF: left ventricle ejection fraction; DT: deceleration time of E wave; ratio, ratio of early diastolic annular velocity to peak early diastolic annular wave velocity; ratio: ratio of early diastolic annular velocity to peak late diastolic arterial filling velocity; LAVI: left atrium volume index.